http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101936766-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-04 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6863 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate | 2016-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101936766-B1 |
| titleOfInvention | Novel Method for In Vitro Screening Inhibitory Substance of Allergy and Agent for Treating Allergy Disease |
| abstract | (A) treating the cells with phorbol 12-myristate 13-acetate and a test substance; (b) measuring the amount of Thymic stromal lymphopoietin in the thymus substrate secreted from the cell; And (c) confirming that the amount of lymphocyte thymus secretion in the thymus substrate is reduced compared to cells treated with only pornol 12-myristate 13-acetate, and a screening method for an allergic disease agent Method, the screening method according to the present invention can easily select allergy suppressing substances and therapeutic agents for allergic diseases since it is simple and low in statistical error and high in reliability. |
| priorityDate | 2016-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 25.